Hermetica Superfood Encyclopedia
The Short Answer
Hesperidin is a flavanone glycoside that exerts antioxidant, anti-inflammatory, and cardiovascular effects by scavenging reactive oxygen species, upregulating glutathione-dependent antioxidant enzymes, inhibiting proinflammatory cytokine production, and modulating ACE and lipid metabolism pathways. In a clinical trial of type 2 diabetes patients, 500 mg/day hesperidin administered for 6 weeks produced measurable antihypertensive effects, reduced tumor necrosis factor-alpha, and attenuated the decline in serum antioxidant capacity.
CategoryCompound
GroupCompound
Evidence LevelPreliminary
Primary Keywordhesperidin benefits
Hesperidin — botanical close-up
Health Benefits
**Antihypertensive Effect**
Hesperidin supplementation at 500 mg/day over 6 weeks has demonstrated blood pressure-lowering effects in type 2 diabetes patients, likely mediated through antioxidative enzyme upregulation, improved endothelial function, and reduced oxidative stress on vascular tissue.
**Anti-inflammatory Activity**
Hesperidin inhibits neutrophil recruitment, reduces edema, and suppresses proinflammatory cytokines including TNF-alpha and interleukins; in acetic acid-induced colitis mouse models at 100 mg/kg, it significantly reduced colonic inflammation and boosted local antioxidant defenses.
**Antioxidant Defense Enhancement**
As a free-radical scavenger, hesperidin boosts endogenous glutathione peroxidase, superoxide dismutase, and catalase activity, thereby protecting cells from oxidative damage linked to chronic disease progression.
**Anticancer Properties**
Preclinical studies at 60 mg/kg/day in non-small cell lung cancer mouse models show hesperidin induces apoptosis and cell cycle arrest, inhibits tumor angiogenesis and metastasis, upregulates miRNA-132 to suppress the ZEB2 transcription factor, and reduces chemoresistance.
**Neuroprotective Effects**
In AlCl3-induced Alzheimer's disease rat models at 100 mg/kg, hesperidin prevented cognitive deficits measured by maze testing, reduced neuroinflammation and oxidative stress, and enhanced expression of neural growth factors while reducing apoptotic signaling in hippocampal tissue.
**Cardiovascular Metabolic Benefits**
Hesperidin favorably modulates cardiovascular risk factors including serum glucose, triglycerides, LDL cholesterol, and platelet aggregation, with mechanisms tied to antioxidative enzyme induction and suppression of lipid peroxidation in vascular tissue.
**Antidiabetic Support**
Clinical and preclinical evidence suggests hesperidin improves glycemic markers and reduces oxidative stress biomarkers in diabetic states, with the 6-week 500 mg/day human trial demonstrating improvements in antioxidant capacity in type 2 diabetic patients.
Origin & History
Natural habitat
Hesperidin is a flavanone glycoside bioflavonoid found in highest concentrations in the peel and membranes of citrus fruits, particularly sweet oranges (Citrus sinensis), lemons (Citrus limon), and grapefruits, which are cultivated across subtropical and Mediterranean regions worldwide. Commercial hesperidin is primarily extracted as a byproduct of the citrus juice industry, recovered from the albedo (white pith) and peel waste streams during orange and lemon processing. Its natural abundance in the citrus plant is believed to serve protective roles against UV radiation, pathogens, and herbivores, and it accumulates most heavily in unripe fruit before declining as the fruit matures.
“Hesperidin does not carry an independent history of use as an isolated compound in traditional medicine; rather, its traditional context is inseparable from the long history of citrus fruits in Mediterranean, Middle Eastern, East Asian, and Ayurvedic healing traditions, where citrus peel and juice were used for digestive support, fever reduction, and general vitality for thousands of years. In traditional Chinese medicine, dried citrus peel (chen pi, from Citrus reticulata) has been prescribed for centuries to resolve phlegm, improve digestion, and regulate qi, and its bioactive content is now understood to include hesperidin and related flavanones. European folk medicine similarly employed bitter orange (Citrus aurantium) and lemon preparations as tonics and anti-inflammatory remedies, though hesperidin's isolation and chemical identification did not occur until the 19th–20th century advancement of phytochemistry. The commercial emergence of hesperidin as a purified supplement began in the 20th century when researchers categorized flavanones under the now-defunct classification of 'Vitamin P' (bioflavonoids), reflecting early recognition of their vascular-protective properties, though this classification was later withdrawn due to insufficient evidence of essential nutrient status.”Traditional Medicine
Scientific Research
The current body of human clinical evidence for hesperidin is limited; the most cited human study involves type 2 diabetes patients receiving 500 mg/day for 6 weeks, demonstrating antihypertensive and anti-inflammatory effects including reduced TNF-alpha, but this study lacks published sample size, effect sizes, or peer-reviewed replication data, making confidence in its findings preliminary. Preclinical evidence is substantially more developed, with multiple controlled animal studies demonstrating dose-dependent anti-inflammatory effects (100 mg/kg in colitis models), anticancer activity (60 mg/kg/day in lung cancer xenograft models), and neuroprotection (100 mg/kg in AlCl3-induced cognitive impairment models), providing mechanistic plausibility but limited direct translatability to human outcomes. Bioavailability research, including comparative rat pharmacokinetic studies of alpha-glucosyl hesperidin versus hesperetin, and mechanistic in vitro work on SARS-CoV-2 spike protein binding modulation (13 hydrogen bond interactions with ACE2 receptor-binding domain residues), adds molecular depth but does not constitute clinical proof of efficacy. Overall, hesperidin sits in the preliminary-to-moderate evidence tier, with well-characterized mechanisms and promising preclinical data but an urgent need for large, well-powered, randomized controlled trials in human populations.
Preparation & Dosage
Traditional preparation
**Standard Hesperidin Capsule/Tablet**
500 mg/day used in the primary reported human clinical trial for antihypertensive and anti-inflammatory effects over 6 weeks; general supplemental range is 100–500 mg/day
**Alpha-Glucosyl Hesperidin (AGH)**
A transglucosylated derivative produced via cyclodextrin glucanotransferase enzyme treatment, offering significantly improved water solubility and comparable plasma bioavailability to hesperetin in rat models; doses mirror standard hesperidin ranges.
**Nanoformulations**
Nanotechnology-based delivery systems (nanoparticles, liposomes, nanoemulsions) have been developed to enhance aqueous solubility, bioavailability, and cellular uptake of hesperidin; clinical doses in these forms are not yet standardized.
**Dietary Food Source**
Consumed passively through citrus fruit consumption (orange juice, lemon peel, grapefruit); concentrations in whole fruits are highest in the albedo and peel, though precise mg-per-serving values vary widely by cultivar and ripeness.
**Standardization**
Commercial hesperidin extracts are typically standardized to 90–98% hesperidin content by HPLC; buyers should verify certificates of analysis for purity and the absence of adulterants.
**Timing Note**
Due to dependence on colonic microbiota for conversion to bioavailable metabolites (hesperetin, HMPPA, hippuric acid), hesperidin is best taken with meals to support gastrointestinal transit and microbial metabolism; individuals with dysbiosis may have significantly reduced bioavailability.
Nutritional Profile
Hesperidin is a pure flavanone glycoside compound (molecular weight 610.57 g/mol) with no caloric, macronutrient, or micronutrient contribution in supplemental form. Its primary bioactive identity is as a polyphenolic phytochemical with the structural designation 3,5,7-trihydroxyflavanone 7-rhamnoglucoside, consisting of a hesperetin aglycone linked to a rutinose disaccharide. Bioavailability is inherently low due to poor water solubility, limited passive intestinal absorption of the intact glycoside, and dependence on colonic bacterial β-glucosidase hydrolysis to release hesperetin prior to absorption; this creates significant inter-individual variation based on gut microbiome composition. Key metabolites detected in human plasma and urine after hesperidin ingestion include hesperetin, HMPPA (3-(3′-hydroxy-4′-methoxyphenyl)propanoic acid), hippuric acid, 4-hydroxyhippuric acid, and 3-hydroxy-3-(3′-hydroxyphenyl)propanoic acid, which collectively represent the systemically active fraction responsible for observed biological effects.
How It Works
Mechanism of Action
Hesperidin acts as a direct radical scavenger due to its polyphenolic catechol-like B-ring structure, while simultaneously upregulating endogenous glutathione-dependent antioxidant enzymes (glutathione peroxidase, superoxide dismutase, catalase) to neutralize reactive oxygen species and reduce lipid peroxidation. Its anti-inflammatory mechanism involves suppression of neutrophil chemotaxis, inhibition of NF-κB-mediated proinflammatory cytokine transcription (TNF-alpha, IL-1β, IL-6), and activation of MAPK signaling pathways that modulate immune responses. Anticancer activity is mediated through induction of intrinsic apoptotic cascades, G1/S cell cycle arrest, inhibition of matrix metalloproteinases that facilitate metastasis, suppression of angiogenic factors like VEGF, and upregulation of miRNA-132 which silences the ZEB2 epithelial-mesenchymal transition transcription factor in lung cancer cells. Neuroprotective effects arise from combined suppression of neuroinflammatory cytokines, enhancement of BDNF and NGF expression, and inhibition of apoptotic pathways in hippocampal neurons, while its gut microbiota-dependent metabolism to hesperetin and phenolic acids (HMPPA, hippuric acid, 3-hydroxy-3-(3′-hydroxyphenyl)propanoic acid) generates systemically bioavailable metabolites that contribute to peripheral anti-inflammatory and cardiovascular effects.
Clinical Evidence
The primary human clinical data for hesperidin consists of a single reported trial in type 2 diabetes patients using 500 mg/day for 6 weeks, which found antihypertensive effects, reduced serum TNF-alpha, and attenuated decline in antioxidant capacity; however, this trial's sample size, randomization status, blinding, and precise effect magnitudes are not fully available in published literature, limiting its interpretive value. No large-scale randomized controlled trials, dose-response studies, or multi-center trials in healthy or cardiovascular populations have been reported in the accessible evidence base, representing a significant gap in the clinical development of this compound. Preclinical models provide internally consistent support for hesperidin's anti-inflammatory, antioxidant, anticancer, and neuroprotective properties, but animal-to-human extrapolation remains uncertain given hesperidin's known low oral bioavailability and dependence on gut microbiota metabolism for active metabolite generation. Confidence in hesperidin's clinical utility as an antihypertensive and anti-inflammatory agent is currently low-to-moderate, justified primarily by biological plausibility and mechanistic clarity rather than robust human trial replication.
Safety & Interactions
At the doses studied (100–500 mg/day in humans), hesperidin appears to be well tolerated, with no adverse effects, hepatotoxicity signals, or serious adverse events reported in available clinical or preclinical literature; however, the extremely limited volume of human safety data means the true tolerability profile at higher doses or with long-term use remains undetermined. No formal drug interaction studies have been published for isolated hesperidin supplementation, but as a flavonoid, theoretical interactions with CYP450 enzymes (particularly CYP3A4 inhibition, a property shared by other citrus flavonoids such as naringenin) are plausible and could affect metabolism of calcium channel blockers, statins, immunosuppressants, and anticoagulants, warranting caution in polypharmacy patients. Individuals taking anticoagulant or antiplatelet medications (warfarin, clopidogrel, aspirin) should exercise caution given hesperidin's documented inhibitory effects on platelet aggregation, which may potentiate bleeding risk. There are no established contraindications for pregnancy or lactation based on current evidence, but given the absence of controlled human safety trials in these populations, supplemental use beyond dietary citrus consumption is not recommended without medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
hesperetin-7-O-rutinoside3,5,7-trihydroxyflavanone 7-rhamnoglucosideVitamin P bioflavonoidAGH (alpha-glucosyl hesperidin)citrus bioflavonoid
Frequently Asked Questions
What is hesperidin good for?
Hesperidin is primarily studied for its antihypertensive, anti-inflammatory, and antioxidant properties. In a clinical trial of type 2 diabetes patients, 500 mg/day for 6 weeks reduced blood pressure, lowered TNF-alpha, and attenuated the decline in serum antioxidant capacity, while preclinical models support additional benefits including neuroprotection, anticancer activity, and cardiovascular metabolic improvements.
What is the recommended dose of hesperidin?
The most commonly referenced human dose is 500 mg/day, based on the available clinical trial in type 2 diabetes patients conducted over 6 weeks. General supplemental ranges in research literature span 100–500 mg/day for humans, while animal studies have used 60–100 mg/kg doses; standardized extracts are typically 90–98% hesperidin purity.
Does hesperidin interact with any medications?
No formal drug interaction trials for hesperidin have been published, but its platelet aggregation-inhibiting properties create theoretical bleeding risk when combined with anticoagulants or antiplatelets such as warfarin, clopidogrel, or aspirin. As a citrus flavonoid, hesperidin may also theoretically inhibit CYP3A4 enzymes, potentially affecting the metabolism of statins, calcium channel blockers, and immunosuppressants, so patients on these medications should consult a healthcare provider before supplementing.
Is hesperidin the same as vitamin C?
No, hesperidin and vitamin C are distinct compounds, though they were historically grouped together under the term 'Vitamin P' (bioflavonoids) due to their co-occurrence in citrus fruits and complementary vascular-protective effects. Hesperidin is a flavanone glycoside polyphenol, while vitamin C (ascorbic acid) is a water-soluble essential vitamin; they share antioxidant properties but act through different molecular mechanisms and have different deficiency consequences.
Why is hesperidin poorly absorbed and how can absorption be improved?
Hesperidin has low oral bioavailability because it is poorly water-soluble and is not efficiently absorbed intact in the small intestine; it requires hydrolysis by colonic bacterial β-glucosidases to release hesperetin before significant absorption can occur, making bioavailability highly dependent on individual gut microbiome composition. Bioavailability can be improved using alpha-glucosyl hesperidin (AGH), a transglucosylated derivative with enhanced water solubility that achieves comparable hesperetin plasma levels in preclinical models, or through nanoparticle and liposomal delivery formulations designed to improve solubility and mucosal uptake.
What foods contain hesperidin naturally?
Hesperidin is found primarily in citrus fruits, particularly in the peel and white pith of oranges, lemons, and grapefruits. Other sources include tangerines, mandarin oranges, and to a lesser extent in other plant-based foods. However, the concentration in whole foods is typically lower than supplement doses used in clinical studies, making supplementation necessary to achieve the 500 mg daily amounts shown effective in research.
Is hesperidin safe for people with diabetes?
Yes, hesperidin appears particularly beneficial for people with type 2 diabetes, as clinical research has demonstrated blood pressure-lowering effects in this population at 500 mg/day over 6 weeks. The compound works through antioxidative mechanisms and improved endothelial function rather than affecting blood glucose directly. However, individuals with diabetes should consult their healthcare provider before supplementing, especially if taking blood pressure medications.
How does hesperidin's anti-inflammatory effect work in the body?
Hesperidin reduces inflammation by inhibiting neutrophil recruitment to inflamed tissues and decreasing edema formation, making it useful for inflammatory conditions. The mechanism involves modulating oxidative stress and vascular function, which helps reduce inflammatory signaling in blood vessels and tissues. This anti-inflammatory activity contributes to its broader effects on cardiovascular and metabolic health.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w hesperidin-hesperetin-7-o-rutinoside curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
